206 related articles for article (PubMed ID: 24379207)
1. Activities of tobramycin and polymyxin E against Pseudomonas aeruginosa biofilm-coated medical grade endotracheal tubes.
Tarquinio K; Confreda K; Shurko J; LaPlante K
Antimicrob Agents Chemother; 2014; 58(3):1723-9. PubMed ID: 24379207
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Pseudomonas aeruginosa Biofilm Present in Endotracheal Tubes by Poly-l-Lysine.
Guillon A; Fouquenet D; Morello E; Henry C; Georgeault S; Si-Tahar M; Hervé V
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104272
[TBL] [Abstract][Full Text] [Related]
3. Synergistic Meropenem-Tobramycin Combination Dosage Regimens against Clinical Hypermutable Pseudomonas aeruginosa at Simulated Epithelial Lining Fluid Concentrations in a Dynamic Biofilm Model.
Bilal H; Bergen PJ; Kim TH; Chung SE; Peleg AY; Oliver A; Nation RL; Landersdorfer CB
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427301
[TBL] [Abstract][Full Text] [Related]
4. Optimization of an in vitro Pseudomonas aeruginosa Biofilm Model to Examine Antibiotic Pharmacodynamics at the Air-Liquid Interface.
Tan X; Huang Y; Rana A; Singh N; Abbey TC; Chen H; Toth PT; Bulman ZP
NPJ Biofilms Microbiomes; 2024 Mar; 10(1):16. PubMed ID: 38429317
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against Pseudomonas aeruginosa biofilms.
Armijo LM; Wawrzyniec SJ; Kopciuch M; Brandt YI; Rivera AC; Withers NJ; Cook NC; Huber DL; Monson TC; Smyth HDC; Osiński M
J Nanobiotechnology; 2020 Feb; 18(1):35. PubMed ID: 32070354
[TBL] [Abstract][Full Text] [Related]
7. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.
Díez-Aguilar M; Morosini MI; Köksal E; Oliver A; Ekkelenkamp M; Cantón R
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746
[No Abstract] [Full Text] [Related]
8. Hyperthermia Prevents
Palau M; Muñoz E; Larrosa N; Gomis X; Márquez E; Len O; Almirante B; Gavaldà J
Microbiol Spectr; 2023 Feb; 11(1):e0280722. PubMed ID: 36472442
[TBL] [Abstract][Full Text] [Related]
9.
Badal D; Jayarani AV; Kollaran MA; Kumar A; Singh V
J Med Microbiol; 2020 Jun; 69(6):906-919. PubMed ID: 32459613
[No Abstract] [Full Text] [Related]
10. The prevention of biofilm colonization by multidrug-resistant pathogens that cause ventilator-associated pneumonia with antimicrobial-coated endotracheal tubes.
Raad II; Mohamed JA; Reitzel RA; Jiang Y; Dvorak TL; Ghannoum MA; Hachem RY; Chaftari AM
Biomaterials; 2011 Apr; 32(11):2689-94. PubMed ID: 21295343
[TBL] [Abstract][Full Text] [Related]
11. Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling.
Bilal H; Tait JR; Lang Y; Zhou J; Bergen PJ; Peleg AY; Bulitta JB; Oliver A; Nation RL; Landersdorfer CB
Antimicrob Agents Chemother; 2022 Mar; 66(3):e0220321. PubMed ID: 35041509
[TBL] [Abstract][Full Text] [Related]
12. Spatiotemporal pharmacodynamics of meropenem- and tobramycin-treated Pseudomonas aeruginosa biofilms.
Haagensen J; Verotta D; Huang L; Engel J; Spormann AM; Yang K
J Antimicrob Chemother; 2017 Dec; 72(12):3357-3365. PubMed ID: 28961810
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions.
McCaughey G; McKevitt M; Elborn JS; Tunney MM
J Cyst Fibros; 2012 May; 11(3):163-72. PubMed ID: 22138067
[TBL] [Abstract][Full Text] [Related]
14. Biofilm formation on three different endotracheal tubes: a prospective clinical trial.
Thorarinsdottir HR; Kander T; Holmberg A; Petronis S; Klarin B
Crit Care; 2020 Jun; 24(1):382. PubMed ID: 32600373
[TBL] [Abstract][Full Text] [Related]
15. Effect of pH on the antimicrobial susceptibility of planktonic and biofilm-grown clinical Pseudomonas aeruginosa isolates.
Moriarty TF; Elborn JS; Tunney MM
Br J Biomed Sci; 2007; 64(3):101-4. PubMed ID: 17910277
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole genome sequencing.
Breen SKJ; Harper M; López-Causapé C; Rogers KE; Tait JR; Smallman TR; Lang Y; Lee WL; Zhou J; Zhang Y; Bulitta JB; Nation RL; Oliver A; Boyce JD; Landersdorfer CB
Int J Antimicrob Agents; 2024 Jun; 63(6):107161. PubMed ID: 38561094
[TBL] [Abstract][Full Text] [Related]
17. Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activity.
Agyeman AA; López-Causapé C; Rogers KE; Lucas DD; Cortés-Lara S; Gomis-Font MA; Fraile-Ribot P; Figuerola J; Lang Y; Franklyn ERT; Lee WL; Zhou J; Zhang Y; Bulitta JB; Boyce JD; Nation RL; Oliver A; Landersdorfer CB
Int J Antimicrob Agents; 2023 Sep; 62(3):106887. PubMed ID: 37315906
[TBL] [Abstract][Full Text] [Related]
18. Breaking the Vicious Cycle of Antibiotic Killing and Regrowth of Biofilm-Residing
Müsken M; Pawar V; Schwebs T; Bähre H; Felgner S; Weiss S; Häussler S
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297365
[TBL] [Abstract][Full Text] [Related]
19. S-Nitroso-N-acetylpenicillamine impregnated endotracheal tubes for prevention of ventilator-associated pneumonia.
Homeyer KH; Singha P; Goudie MJ; Handa H
Biotechnol Bioeng; 2020 Jul; 117(7):2237-2246. PubMed ID: 32215917
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
Tré-Hardy M; Traore H; El Manssouri N; Vanderbist F; Vaneechoutte M; Devleeschouwer MJ
Int J Antimicrob Agents; 2009 Oct; 34(4):370-4. PubMed ID: 19505804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
